diff --git a/data/beta_alanine_lab/download_manifest.csv b/data/beta_alanine_lab/download_manifest.csv index e7546f0..ef96f2b 100644 --- a/data/beta_alanine_lab/download_manifest.csv +++ b/data/beta_alanine_lab/download_manifest.csv @@ -15,7 +15,7 @@ church2017,"Church et al. 2017, J Am Coll Nutr, 6 vs 12 g/day",https://doi.org/1 decombaz2012,"Decombaz et al. 2012, Amino Acids, slow-release tablets and paresthesia",https://doi.org/10.1007/s00726-011-1169-7,aminoacids_2012_decombaz_slow_release_paresthesia.pdf,paywalled,ok,787f274a04cbc1ef146bd081cf7f245ac1b2ba82b0c89b8fc8c2d24fcb645edd,465532,2026-11-14,"Tingling check, sustained release; erratum 10.1007/s00726-013-1557-2 corrects Table 1 units; supplied by the user 2026-11-14" decombaz2013_erratum,"Decombaz et al. 2013, erratum to the 2012 paper (Table 1 units)",https://doi.org/10.1007/s00726-013-1557-2,aminoacids_2013_decombaz_erratum_table1_units.pdf,paywalled,ok,167f01447238afa575686282c5498ac3970749f6d51d4f4571eb26004f5a826d,162775,2026-11-14,Read with decombaz2012; supplied by the user 2026-11-14 stegen2013,"Stegen et al. 2013, MSSE 45(8):1478-85, meal coingestion",https://pubmed.ncbi.nlm.nih.gov/23439427/,msse_2013_stegen_meal_coingestion_carnosine.pdf,paywalled,ok,42c944f97076c21ddcb449cfbb2e7308a9db332a045e9c41bb55e3eb4dc30419,1149605,2026-11-14,Meal toggle decision; supplied by the user 2026-11-14 -harris2009,"Harris et al. 2009, FASEB J 23(1) abstract, controlled-release washout",,faseb_2009_harris_controlled_release_washout_abstract.pdf,abstract_only,manual_needed,,,,"Cited by Yamaguchi 2021 for t1/2 8.6 wk; conference abstract, optional" +harris2009,"Harris et al. 2009, FASEB J 23(1) abstract, controlled-release washout",https://doi.org/10.1096/fasebj.23.1_supplement.599.4,faseb_2009_harris_controlled_release_washout_abstract.txt,abstract_only,ok,50916dc50d3e24d99a40d944d9bee840872a01ca5675f99db01e2c063f6d7861,1391,2026-11-16,"Conference abstract text pasted by the user from Wiley 2026-11-16. Confirms +15.4 (25.9 to 41.3 mmol/kg dm) and t1/2 8.6 wk. n = 7, no control group, product from the manufacturer; user flags it as questionable" baguet2012,"Baguet et al. 2012, Amino Acids 43:13-20, sex, age and heritability",https://doi.org/10.1007/s00726-011-1197-3,aminoacids_2012_baguet_carnosine_sex_age_heritability.pdf,paywalled,ok,4a4aa2c2395ba932863c68d1a6a19196f1cc0ad7f63672ed4448ba4030e3cda6,306339,2026-11-15,Supplied by the user 2026-11-15. MRS carnosine in 263 people aged 9-83; older-adults baseline candidate delfavero2012,"del Favero et al. 2012, Amino Acids 43:49-56, elderly 60-80 y",https://doi.org/10.1007/s00726-011-1190-x,aminoacids_2012_delfavero_beta_alanine_elderly.pdf,paywalled,ok,e36dce5b8f52f02299711ebe3b2bf62be300acaf1705d040dfb979edc3a90030,223775,2026-11-15,Supplied by the user 2026-11-15. 3.2 g/day for 12 wk in elderly; carnosine relative to water only saunders2020,"Saunders et al. 2020, Eur J Nutr 59:57-65, 24 wk muscle taurine",https://doi.org/10.1007/s00394-018-1881-0,eurjnutr_2020_saunders_beta_alanine_muscle_taurine.pdf,paywalled,ok,bd697b000b8470811337390042830d79aa70911aab933dd7021aa54e04dcab75,850712,2026-11-15,Supplied by the user 2026-11-15. 24 wk at 6.4 g/day did not change muscle taurine @@ -46,3 +46,6 @@ matthews1987,"Matthews and Traut 1987, regulation of rat beta-ureidopropionase", perim2019,"Perim et al. 2019, optimizing the muscle carnosine response",https://doi.org/10.3389/fnut.2019.00135,frontnutr_2019_perim_optimizing_carnosine_response.pdf,open_pdf,ok,7c0b43d4dee964f61cf6082894b4f48123b26d62862268132c58c81ddcb01b19,1370634,2026-11-15,"Supplied by the user 2026-11-15. Accepted manuscript. Review of dose, duration, form, diet, exercise" varanoske2019,"Varanoske et al. 2019, sustained-release vs rapid-release beta-alanine",https://doi.org/10.1007/s00726-018-2609-4,aminoacids_2019_varanoske_sustained_vs_rapid_release.pdf,paywalled,ok,ebe2defdeb69aee7acf869732efb384dfce6b3efd096dd84f1e510550548f4c9,959759,2026-11-15,Supplied by the user 2026-11-15. Same 6 g/day as sustained or rapid release; VL carnosine and histidine painelli2018,"de Salles Painelli et al. 2018, HIIT and muscle carnosine in vegetarians",https://doi.org/10.1249/MSS.0000000000001697,msse_2018_painelli_hiit_vegetarian_carnosine.pdf,paywalled,ok,564dc520d594d2b624d7c6b5544b5d9ecc36f479a4675b9694b3ab12bfda31bc,2000454,2026-11-15,Supplied by the user 2026-11-15. Published-ahead-of-print version. Carnosine rose with training without dietary beta-alanine +nemezio2021,"Nemezio et al. 2021, carnosine in paralyzed and active muscle",https://doi.org/10.1152/ajpregu.00360.2020,ajpregu_2021_nemezio_spinal_cord_injury_carnosine.pdf,paywalled,ok,9e64a06763975ef6ac0f550d0e31443c51257fb50afe082dadbd376f0c39985a,1276121,2026-11-16,"Supplied by the user 2026-11-16. Athletes with paraplegia, 6.4 g/day for 28 days; inactive VL and active deltoid loaded similarly" +varanoske2017,"Varanoske et al. 2017, beta-alanine in men and women",https://doi.org/10.1016/j.nutres.2017.10.002,nutres_2017_varanoske_men_women_carnosine_histidine.pdf,paywalled,ok,222157357fd41f6bfe538f76d7cd690b0baf0b704f915a5552c93fc4c9680041,451352,2026-11-16,Supplied by the user 2026-11-16 (published version; accepted manuscript kept beside it). 6 g/day sustained release 28 days; sex difference unclear; histidine unchanged +harris2008,"Harris et al. 2008, plasma profile of controlled-release beta-alanine",https://doi.org/10.1096/fasebj.22.1_supplement.701.9,faseb_2008_harris_controlled_release_plasma_profile.txt,abstract_only,ok,4289a6a1597e665460c14c177df4bab4153b5ada36429a8363bc00722c98ff9b,1302,2026-11-16,Conference abstract text pasted by the user from Wiley 2026-11-16. n = 6; product from the manufacturer; user flags it as questionable; not used diff --git a/data/beta_alanine_lab/literature.json b/data/beta_alanine_lab/literature.json index 3bd8c5f..e3d2371 100644 --- a/data/beta_alanine_lab/literature.json +++ b/data/beta_alanine_lab/literature.json @@ -316,9 +316,9 @@ }, { "id": "harris2009", - "status": "notArchived", + "status": "archived", "doi": "10.1096/fasebj.23.1_supplement.599.4", - "access": "conference abstract", + "access": "abstract text pasted by the user from Wiley", "citation": "Harris RC et al. 2009, FASEB J 23(S1):599.4. Muscle carnosine with 4 weeks of controlled-release beta-alanine and 6 weeks after", "design": "6.4 g/day sustained release, VL biopsy", "role": "Washout half-life about 60 d and one loading point, both as quoted by Spelnikov 2019 and Yamaguchi 2021", @@ -326,12 +326,17 @@ "loading_observations", "washout_rates" ], - "extraFindings": [], + "extraFindings": [ + { + "text": "7 men, 2 x 800 mg controlled release 4 times daily for 4 weeks: VL carnosine 25.9, 41.3 (4 wk), 38.3 (3 wk after) and 35.4 (6 wk after) mmol/kg dm; first-order decline, t1/2 8.6 wk", + "location": "Abstract" + } + ], "caveats": [ - "Never read directly; optional" + "Conference abstract, not peer reviewed in full; small n and (2009) no control group; tablets from the manufacturer and an author from the manufacturer. The user flags both FASEB abstracts as questionable: acknowledged, no new claims taken from them.", + "Already in the fit as one of four washout studies (60 d) and one loading point (+15.4); the abstract confirms both values. Whether to keep it in the fit is a model decision for the user." ], - "whyNeeded": "Optional: the 60 d washout half-life and +15.4 rise that two archived papers quote; DOI found 2026-11-16, so the abstract may be reachable through Wiley", - "file": "faseb_2009_harris_controlled_release_washout_abstract.pdf" + "file": "faseb_2009_harris_controlled_release_washout_abstract.txt" }, { "id": "baguet2012", @@ -1010,49 +1015,112 @@ }, { "id": "nemezio2021", - "status": "wanted", + "status": "archived", "doi": "10.1152/ajpregu.00360.2020", - "access": "paywalled; postprint on the MMU repository (403 to scripts)", + "access": "paywalled (supplied by the user)", "file": "ajpregu_2021_nemezio_spinal_cord_injury_carnosine.pdf", - "priority": 1, "citation": "Nemezio K et al. 2021, Am J Physiol Regul Integr Comp Physiol 320:R824. Chronic muscle (in)activity and carnosine: athletes with spinal cord injury", - "readVia": "Search snippets and the MSSE 2020 conference abstract (10.1249/01.mss.0000682364.21696.0e)", "extraFindings": [ { - "text": "16 paraplegic male athletes, 6.4 g/day or placebo for 28 days (2:1); carnosine rose similarly in the inactive vastus lateralis and the active deltoid; baseline higher in the paralyzed muscle, attributed to a fibre-type shift", - "location": "Abstract, as summarized" + "text": "Carnosine rose similarly in the inactive VL (+68.9 +/- 55.1%) and the active deltoid (+90.5 +/- 51.4%); no change on placebo", + "location": "Abstract" + }, + { + "text": "Baseline higher in the inactive VL than the trained deltoid (32.0 vs 20.5 mmol/kg dm) and than active VL of people without paraplegia (21.2), most likely from a type I to type II fibre shift", + "location": "Abstract" + }, + { + "text": "Agrees with Kendrick 2009 (similar loading in trained and untrained muscle); disagrees with Bex 2014 and 2015", + "location": "Discussion" + }, + { + "text": "Cites Hoetker 2018: low-intensity training raised carnosine and high-intensity training lowered it", + "location": "Introduction" } ], - "whyNeeded": "Contradicts Bex 2014 (trained muscles load more) and bears on Bex 2015: if inactivity does not change loading, the training note on the page needs a counterweight. VL biopsy at 6.4 g/day for 28 days is also a loading point in a new population." + "feeds": [], + "role": "Not yet used; counterweight to the Bex training note", + "design": "16 male athletes with paraplegia, 6.4 g/day as four 1.6 g doses of 0.8 g sustained-release tablets (n = 11) or placebo (n = 5), 28 days; biopsies of the active deltoid and inactive VL; whole muscle and single fibres, HPLC", + "caveats": [ + "Percent rises are means of individual percent changes; absolute changes only in figures, so no anchor" + ] }, { "id": "varanoske2017", - "status": "wanted", + "status": "archived", "doi": "10.1016/j.nutres.2017.10.002", - "access": "paywalled", + "access": "paywalled (supplied by the user; published version and accepted manuscript)", "file": "nutres_2017_varanoske_men_women_carnosine_histidine.pdf", - "priority": 2, "citation": "Varanoske AN et al. 2017, Nutr Res 48:16. Beta-alanine raises carnosine in men and women similarly but does not change muscle histidine", - "readVia": "Search snippet", "extraFindings": [ { - "text": "6 g/day for 28 days; carnosine changes likely (men) and very likely (women) greater than placebo, unclear between sexes; muscle histidine unchanged", - "location": "Abstract, as summarized" + "text": "Baseline carnosine 9.07 (men) vs 6.83 (women) mmol/kg wet, P = 0.069", + "location": "Table 1" + }, + { + "text": "Carnosine rise likely (men) and very likely (women) greater than placebo; difference between sexes unclear, 2.50 +/- 4.30 mmol/kg wet", + "location": "Abstract" + }, + { + "text": "Muscle histidine change unclear in both sexes; baseline carnosine not correlated with the change (rho = -0.188)", + "location": "Abstract; Results" } ], - "whyNeeded": "A biopsy loading point at 6 g/day for 28 days split by sex, against the page women preset, and a second study with no histidine fall (with Dolan 2019)." + "feeds": [], + "role": "Not yet used; sex and histidine", + "design": "6 g/day as 2 g sustained-release tablets 3 times daily, 28 days; 6 men and 6 women on beta-alanine, 4 and 4 on placebo analyzed; VL biopsy HPLC", + "caveats": [ + "Magnitude-based inference statistics; small groups; per-group absolute changes only in a figure, so no anchor" + ] }, { "id": "harris2008", - "status": "wanted", + "status": "archived", "doi": "10.1096/fasebj.22.1_supplement.701.9", - "access": "conference abstract", - "file": "faseb_2008_harris_controlled_release_plasma_profile.pdf", - "priority": 3, + "access": "abstract text pasted by the user from Wiley", + "file": "faseb_2008_harris_controlled_release_plasma_profile.txt", "citation": "Harris RC et al. 2008, FASEB J 22(S1):701.9. Plasma concentration-time profile of controlled-release beta-alanine", - "readVia": "Crossref title only", - "extraFindings": [], - "whyNeeded": "Low priority: sustained-release plasma curve from the formulation most loading studies used; would sit beside Decombaz 2012 for the flatter-curve question." + "extraFindings": [ + { + "text": "Peak 219 uM in water (back to about 10 uM at 3 h), 126 uM with 2 tablets and 177 uM with 4, both above 50 uM at 3 h; AUC 286, 309 and 518 uM.h; 2 tablets bioequivalent to the solution without paresthesia", + "location": "Abstract" + } + ], + "design": "3 men and 3 women: 1600 mg in water vs 2 or 4 x 800 mg controlled-release tablets; capillary plasma over 6 h, HPLC", + "role": "Acknowledged only; not used", + "feeds": [], + "caveats": [ + "Conference abstract, not peer reviewed in full; small n and (2009) no control group; tablets from the manufacturer and an author from the manufacturer. The user flags both FASEB abstracts as questionable: acknowledged, no new claims taken from them.", + "Consistent with Decombaz 2012 (248 vs 82 uM after 1.6 g plain vs slow release)" + ] + }, + { + "id": "kendrick2009", + "status": "citedOnly", + "doi": null, + "citation": "Kendrick IP et al. 2009. Beta-alanine and isokinetic training, carnosine in type I and II fibres", + "readVia": "Cited by Nemezio 2021", + "extraFindings": [ + { + "text": "Similar carnosine accretion in trained and untrained muscle groups (HPLC)", + "location": "as cited by Nemezio 2021" + } + ], + "whyNeeded": null + }, + { + "id": "hoetker2018", + "status": "citedOnly", + "doi": null, + "citation": "Hoetker D et al. 2018. Exercise intensity and muscle carnosine", + "readVia": "Cited by Nemezio 2021", + "extraFindings": [ + { + "text": "Low-intensity training increased muscle carnosine and high-intensity training decreased it", + "location": "as cited by Nemezio 2021" + } + ], + "whyNeeded": null } ], "searches": [ @@ -1134,6 +1202,15 @@ "women, older adults, obesity trials" ], "found": "New: nemezio2021 (inactive muscle loads as well as active), varanoske2017 (men and women), harris2009 DOI, harris2008. Matthews 2025 obesity trial did not measure carnosine. No PK model, no steady-state 24 h urine study, no uracil flux figure, no TauT knockout carnosine data. One search summary misattributed carnosine synthase Km (1.0-2.3 mM) as a muscle uptake Km; discarded." + }, + { + "date": "2026-11-16", + "question": "What do Nemezio 2021, Varanoske 2017 and the two Harris FASEB abstracts show?", + "tried": [ + "full text of nemezio2021 and varanoske2017", + "abstract text of harris2008 and harris2009 pasted by the user" + ], + "found": "Nemezio: inactive and active muscle loaded similarly, against Bex. Varanoske 2017: no clear sex difference in loading, histidine unchanged. Harris 2009 confirms the values already in the fit (+15.4, t1/2 8.6 wk); Harris 2008 plasma peaks fit Decombaz. The FASEB abstracts are acknowledged with caveats and give no new claims." } ], "openQuestions": [ diff --git a/js/beta_alanine_lab/beta-alanine-data.js b/js/beta_alanine_lab/beta-alanine-data.js index 60dab5a..c520754 100644 --- a/js/beta_alanine_lab/beta-alanine-data.js +++ b/js/beta_alanine_lab/beta-alanine-data.js @@ -86,8 +86,8 @@ export const SOURCES = Object.freeze({ }, "harris2009": { "label": "Harris et al. 2009, FASEB J 23(1) abstract, controlled-release washout", - "url": null, - "archived": false + "url": "https://doi.org/10.1096/fasebj.23.1_supplement.599.4", + "archived": true }, "baguet2012": { "label": "Baguet et al. 2012, Amino Acids 43:13-20, sex, age and heritability", @@ -238,6 +238,21 @@ export const SOURCES = Object.freeze({ "label": "de Salles Painelli et al. 2018, HIIT and muscle carnosine in vegetarians", "url": "https://doi.org/10.1249/MSS.0000000000001697", "archived": true + }, + "nemezio2021": { + "label": "Nemezio et al. 2021, carnosine in paralyzed and active muscle", + "url": "https://doi.org/10.1152/ajpregu.00360.2020", + "archived": true + }, + "varanoske2017": { + "label": "Varanoske et al. 2017, beta-alanine in men and women", + "url": "https://doi.org/10.1016/j.nutres.2017.10.002", + "archived": true + }, + "harris2008": { + "label": "Harris et al. 2008, plasma profile of controlled-release beta-alanine", + "url": "https://doi.org/10.1096/fasebj.22.1_supplement.701.9", + "archived": true } });